Target Price | €28.05 |
Price | €27.48 |
Potential | 2.08% |
Number of Estimates | 19 |
19 Analysts have issued a price target Bayer 2026 . The average Bayer target price is €28.05. This is 2.08% higher than the current stock price. The highest price target is €36.00 31.00% , the lowest is €22.00 19.94% . | |
A rating was issued by 22 analysts: 9 Analysts recommend Bayer to buy, 13 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Bayer stock has an average upside potential 2026 of 2.08% . Most analysts recommend the Bayer stock at Hold. |
19 Analysts have issued a sales forecast Bayer 2025 . The average Bayer sales estimate is €46.1b . This is 0.99% lower than the revenue of the last 12 months(TTM). The highest sales forecast is €46.9b 0.69% , the lowest is €45.0b 3.40% .
This results in the following potential growth metrics:
2024 | €46.6b | 2.16% |
---|---|---|
2025 | €46.1b | 1.05% |
2026 | €46.8b | 1.59% |
2027 | €48.0b | 2.39% |
2028 | €49.5b | 3.19% |
2029 | €50.7b | 2.36% |
19 Analysts have issued an Bayer EBITDA forecast 2025. The average Bayer EBITDA estimate is €9.3b . This is 15.63% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is €9.5b 19.26% , the lowest is €8.1b 0.62% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | €12.8b | 30.71% |
---|---|---|
2025 | €9.3b | 27.57% |
2026 | €9.7b | 4.94% |
2027 | €10.2b | 5.31% |
2028 | €10.4b | 2.04% |
2029 | €10.4b | 0.05% |
2024 | 27.42% | 29.18% |
---|---|---|
2025 | 20.07% | 26.80% |
2026 | 20.73% | 3.29% |
2027 | 21.32% | 2.85% |
2028 | 21.09% | 1.08% |
2029 | 20.59% | 2.37% |
11 Bayer Analysts have issued a net profit forecast 2025. The average Bayer net profit estimate is €1.6b . This is 148.56% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is €2.1b 163.26% , the lowest is €829m 125.48% .
This results in the following potential growth metrics and future Net Margins:
2024 | €-2.6b | 13.23% |
---|---|---|
2025 | €1.6b | 161.90% |
2026 | €2.2b | 41.98% |
2027 | €2.7b | 20.61% |
2028 | €3.1b | 14.09% |
2029 | €2.9b | 7.04% |
2024 | -5.48% | 11.31% |
---|---|---|
2025 | 3.43% | 162.64% |
2026 | 4.79% | 39.65% |
2027 | 5.64% | 17.75% |
2028 | 6.23% | 10.46% |
2029 | 5.66% | 9.15% |
11 Analysts have issued a Bayer forecast for earnings per share. The average Bayer EPS is €1.61 . This is 148.64% higher than earnings per share in the financial year 2024. The highest EPS forecast is €2.09 163.14% , the lowest is €0.84 125.38% .
This results in the following potential growth metrics and future valuations:
2024 | €-2.60 | 13.04% |
---|---|---|
2025 | €1.61 | 161.92% |
2026 | €2.28 | 41.61% |
2027 | €2.75 | 20.61% |
2028 | €3.14 | 14.18% |
2029 | €2.92 | 7.01% |
Current | -8.30 | 6.31% |
---|---|---|
2025 | 17.09 | 305.85% |
2026 | 12.04 | 29.55% |
2027 | 9.98 | 17.11% |
2028 | 8.75 | 12.32% |
2029 | 9.41 | 7.54% |
Based on analysts' sales estimates for 2025, the Bayer stock is valued at an EV/Sales of 1.33 and an P/S ratio of 0.59 .
This results in the following potential growth metrics and future valuations:
Current | 1.32 | 4.35% |
---|---|---|
2025 | 1.33 | 0.75% |
2026 | 1.31 | 1.56% |
2027 | 1.28 | 2.33% |
2028 | 1.24 | 3.10% |
2029 | 1.21 | 2.30% |
Current | 0.59 | 0.03% |
---|---|---|
2025 | 0.59 | 0.99% |
2026 | 0.58 | 1.55% |
2027 | 0.57 | 2.33% |
2028 | 0.55 | 3.11% |
2029 | 0.54 | 2.30% |
Analyst | Rating | Action | Date |
---|---|---|---|
JEFFERIES |
Hold
➜
Hold
|
Unchanged | Apr 06 2025 |
BERENBERG |
Hold
➜
Hold
|
Unchanged | Mar 31 2025 |
DZ BANK |
Buy
➜
Buy
|
Unchanged | Mar 26 2025 |
HSBC |
Hold
➜
Hold
|
Unchanged | Mar 23 2025 |
MWB RESEARCH AG |
Buy
➜
Buy
|
Unchanged | Mar 23 2025 |
REDBURN ATLANTIC |
Neutral
➜
Neutral
|
Unchanged | Mar 21 2025 |
STIFEL EUROPE |
Hold
➜
Hold
|
Unchanged | Mar 09 2025 |
Analyst Rating | Date |
---|---|
Unchanged
JEFFERIES:
Hold
➜
Hold
|
Apr 06 2025 |
Unchanged
BERENBERG:
Hold
➜
Hold
|
Mar 31 2025 |
Unchanged
DZ BANK:
Buy
➜
Buy
|
Mar 26 2025 |
Unchanged
HSBC:
Hold
➜
Hold
|
Mar 23 2025 |
Unchanged
MWB RESEARCH AG:
Buy
➜
Buy
|
Mar 23 2025 |
Unchanged
REDBURN ATLANTIC:
Neutral
➜
Neutral
|
Mar 21 2025 |
Unchanged
STIFEL EUROPE:
Hold
➜
Hold
|
Mar 09 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.